Latest Pivotal bioVenture Partners Investment Advisor LLC Stock Portfolio
$279Million | No. of Holdings #13
Pivotal bioVenture Partners Investment Advisor LLC Performance
2026 Q1+9.98%
YTD+9.98%
2025+25.79%
About Pivotal bioVenture Partners Investment Advisor LLC and 13F Hedge Fund Stock Holdings
On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Pivotal bioVenture Partners Investment Advisor LLC reported an equity portfolio of $279.8 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, , . The fund has invested 28.5% of it's portfolio in VAXCYTE INC and 16% of portfolio in OCULIS HOLDING AG. <br><br> The fund managers got completely rid off RALLYBIO CORP (RLYB) stocks. They significantly reduced their stock positions in BOLT BIOTHERAPEUTICS INC (BOLT), OCULIS HOLDING AG and ARCUTIS BIOTHERAPEUTICS INC (ARQT). Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in AVALO THERAPEUTICS INC (AVTX) and RALLYBIO CORP (RLYB). The fund showed a lot of confidence in some stocks as they added substantially to TREVI THERAPEUTICS INC (TRVI).
Pivotal bioVenture Partners Investment Advisor LLC Equity Portfolio Value
Last Reported on: 14 May, 2026
$279Million
as of May 14, 2026Pivotal bioVenture Partners Investment Advisor LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Pivotal bioVenture Partners Investment Advisor LLC made a return of 9.98% in the last quarter. In trailing 12 months, it's portfolio return was 77.59%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| avalo therapeutics inc | 4,418,280 |
| rallybio corp | 2,696,190 |
New stocks bought by Pivotal bioVenture Partners Investment Advisor LLC
Additions
| Ticker | % Inc. |
|---|---|
| trevi therapeutics inc | 23.63 |
Additions to existing portfolio by Pivotal bioVenture Partners Investment Advisor LLC
Reductions
| Ticker | % Reduced |
|---|---|
| bolt biotherapeutics inc | -54.98 |
| oculis holding ag | -26.58 |
| arcutis biotherapeutics inc | -0.79 |
Pivotal bioVenture Partners Investment Advisor LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| rallybio corp | -1,649,590 |
Pivotal bioVenture Partners Investment Advisor LLC got rid off the above stocks
Sector Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 55.5% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 55.5 |
| Others | 44.5 |
Market Cap. Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- UNALLOCATED
- SMALL-CAP
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 45.6 |
| UNALLOCATED | 44.5 |
| SMALL-CAP | 7.3 |
| MICRO-CAP | 1.6 |
Stocks belong to which Index?
About 48.2% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 51.8 |
| RUSSELL 2000 | 48.2 |
Pivotal bioVenture Partners Investment Advisor LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC has 13 stocks in it's portfolio. About 98.3% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.
$279.78MTotal Value
14.00Positions
14 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Arcutis Biotherapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Arcutis Biotherapeutics Inc over time | 11.42% | 1,355,890 | $31.94M 11.42% | 0.79%decreased 0.79 percentreduced | |
 Avalo Therapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Avalo Therapeutics Inc over time | 1.58% | 295,933 | $4.42M 1.58% | Newnew position | |
 Bolt Biotherapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Bolt Biotherapeutics Inc over time | 0.06% | 42,581 | $172.0K 0.06% | 54.98%decreased 54.98 percentreduced | |
 Immunome Inc Immunome IncIMNM Pivotal bioVenture Partners Investment Advisor LLC's holding in Immunome Inc over time | 5.73% | 732,512 | $16.02M 5.73% | 0%unchanged 0 percentunchanged | |
 Vaxcyte Inc Vaxcyte IncPCVX Pivotal bioVenture Partners Investment Advisor LLC's holding in Vaxcyte Inc over time | 28.5% | 1,372,420 | $79.75M 28.5% | 0%unchanged 0 percentunchanged | |
 Rallybio Corp Rallybio CorpRLYB Pivotal bioVenture Partners Investment Advisor LLC's holding in Rallybio Corp over time | 0.96% | 300,579 | $2.70M 0.96% | Newnew position | |
Rallybio Corp Rallybio CorpRLYB Pivotal bioVenture Partners Investment Advisor LLC's holding in Rallybio Corp over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Recursion Pharmaceuticals In Pivotal bioVenture Partners Investment Advisor LLC's holding in Recursion Pharmaceuticals In over time | 0.65% | 595,518 | $1.83M 0.65% | 0%unchanged 0 percentunchanged | |
 Trevi Therapeutics Inc Pivotal bioVenture Partners Investment Advisor LLC's holding in Trevi Therapeutics Inc over time | 6.62% | 1,553,730 | $18.54M 6.62% | 23.63%increased 23.63 percentadded | |
Ordinary Shares Oculis Holding AgOculis Holding Ag | 15.97% | 1,680,280 | $44.68M 15.97% | 26.58%decreased 26.58 percentreduced | |
Com Shs Evommune IncEvommune Inc | 15.83% | 1,926,940 | $44.30M 15.83% | 0%unchanged 0 percentunchanged | |
Com Maplight Therapeutics IncMaplight Therapeutics Inc | 4.44% | 611,447 | $12.43M 4.44% | 0%unchanged 0 percentunchanged | |
Com Zenas Biopharma IncZenas Biopharma Inc | 4.14% | 591,991 | $11.57M 4.14% | 0%unchanged 0 percentunchanged | |
Com Bioage Labs IncBioage Labs Inc | 4.08% | 653,374 | $11.43M 4.08% | 0%unchanged 0 percentunchanged | |